Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation

Neurogastroenterology and Motility

Volumn 28, Issue 4, 2016, Pages 581-591

  Neri, L ^a   Iovino, P ^b   Altomare, Donato Francesco ^c   Annese, Vito ^d   Badiali, Danilo ^e   Basilisco, Guido ^f   Bassotti, Gabrio ^g   Battaglia, Edda ^h   Bazzocchi, Gabriele ⁱ   Bellini, Massimo ^j   Bendia, Emanuele ^k   Benini, Luigi ^l   Biscaglia, Giuseppe ^m   Biviano, Ivano ⁿ   Bocchini, Renato ^o   Bonventre, Sebastiano ^p   Bossa, Fabrizio ^m   Brandimarte, Giovanni ^q   Cannizzaro, Renato ^r   Cicala, Michele ^s   Cipolletta, Livio ^t   Clara, Virgilio ^u   Cogliandro, Rosanna ^v   Comandini, Giulia ^w   Corazziari, Enrico ⁿ   Crotta, Sergio ^x   Cuomo, Rosario ^y   D'Alba, Lucia ^z   De Giorgi, Francesco ^y   Del Piano, Mario ^aa   Di Fonzo, Michela ^q   Di Mario, Francesco ^ab   Di Stefano, Michele ^ac   D'Onofrio, Vittorio ^ad   Efthymakis, Kostantinos ^ae   Fiore, Pierluigi ^af   Fortuna, Manuela ^ag   Fries, Walter ^ah   Gaetani, Eleonora ^ai   Galeazzi, Francesca ^aj   Gasbarrini, Antonio ^ai   Geccherle, Andrea ^ak   Giangregorio, Francesco ^al   Girardi, Lisa ^am   Grassini, Mario ^h   Groppo, Marzia ^an   Guarnieri, Giovanni ^ab   Lo Cascio, Massimiliano ^ao   Lolli, Roberto ^ap   Luzza, Francesco ^aq   Macarri, Giampiero ^ao   Marino, Maria ^ar   Miraglia, Stefania ^u   Monastra, Santo ^as   Neri, Maria Cristina ^at   Neri, Matteo ^ae   Noris, Roberto Antonio ^au   Orselli, Silvia ^d   Passaretti, Sandro ^av   Paviotti, Alberto ^aw   Pazzi, Paolo ^w   Pilotto, Alberto ^ax   Portincasa, Piero ^ay   Ranaldo, Nunzio ^c   Ravelli, Paolo ^az   Rogai, Francesca ^ba   Sablich, Renato ^bb   Savarino, Vincenzo ^bc   Spinzi, Giancarlo ^bd   Stanghellini, Vincenzo ^be   Tammaro, Leonardo ^bf   Torresan, Francesco ^v   Usai Satta, Paolo ^bg   Valle, C Claudio ^bh   more..

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c POLICLINICO   (Italy)

^d AOUC Careggi   (Italy)

^e POLICLINICO UMBERTO I   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^g UNIVERSITY OF PERUGIA   (Italy)

^h Ospedale Cardinal Massaia   (Italy)

ⁱ Spinal Cord Unit Montecatone Rehabilitation Institute   (Italy)

^j UO Gastroenterologia Universitaria   (Italy)

^k OSPEDALI RIUNITI   (Italy)

^l UNIVERSITY OF VERONA   (Italy)

^m CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

ⁿ SAPIENZA UNIVERSITY OF ROME   (Italy)

^o Casa di Cura Malatesta Novello   (Italy)

^p UNIVERSITY OF PALERMO   (Italy)

^q Ospedale Cristo Re   (Italy)

^r CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^s UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^t UO di Gastroenterologia PO 'A Maresca' ASL Napoli 3 Sud   (Italy)

^u ARNAS Garibaldi Nesima   (Italy)

^v UNIVERSITY OF BOLOGNA   (Italy)

^w UO Gastroenterologia AO Bufalini   (Italy)

^x Unita Gastroenterologia ed E   (Italy)

^y FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^z AO SGiovanni Addolorata   (Italy)

^aa Physical and Rehabilitative Medicine   (Italy)

^ab OSPEDALE CA FONCELLO   (Italy)

^ac UNIVERSITY OF PAVIA   (Italy)

^ad UOC Gastroenterologia AOS San G Moscati   (Italy)

^ae UOD Gastroenterologia ed endoscopia digestiva PO SS Annunziata   (Italy)

^af UO Gastroenterologia   (Italy)

^ag SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^ah UNIVERSITY OF MESSINA   (Italy)

^ai FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^aj UNIVERSITY OF PADOVA   (Italy)

^ak Centro Multispecialistico Malattie Retto Perineale   (Italy)

^al GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^am OSPEDALE DELL'ANGELO   (Italy)

^an ASL 9 Regione Veneto   (Italy)

^ao UO Gastroenterologia Ospedale di Fermo   (Italy)

^ap Aosta Hospital   (Italy)

^aq UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^ar Ospedale di Ortona   (Italy)

^as San Gennaro Hospital   (Italy)

^at UO Gastroenterologia ed endoscopia digestiva Pio Albergo Trivulzio   (Italy)

^au IRCCS S De Bellis di Castellana Grotte (BA)   (Italy)

^av SAN RAFFAELE HOSPITAL   (Italy)

^aw Università degli Studi di Milano ^*  (Italy)

^ax S ANTONIO HOSPITAL   (Italy)

^ay UNIVERSITY OF BARI   (Italy)

^az OSPEDALI RIUNITI   (Italy)

^ba CAREGGI UNIVERSITY HOSPITAL   (Italy)

^bb S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^bc UNIVERSITY OF GENOA   (Italy)

^bd VALDUCE HOSPITAL   (Italy)

^be UNIVERSITY OF BOLOGNA   (Italy)

^bf UOC UOSD Gastroenterologia ed endoscopia digestiva AO S Giovanni Addolorata   (Italy)

^bg BROTZU HOSPITAL   (Italy)

^bh ASL 1 Imperiese SS Cure domiciliari Imperia   (Italy)

more..

Author keywords

Bloating; Chronic constipation; Functional constipation; Irritable bowel syndrome; Patient reported outcomes; Quality of life; Treatment satisfaction

Indexed keywords

ENEMA; PRUCALOPRIDE;

ADULT; ANXIETY; ARTICLE; BLOATING; CLINICAL EXAMINATION; CONSTIPATION; DEPRESSION; FEMALE; GASTROENTEROLOGIST; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 12; SYMPTOM; TERTIARY CARE CENTER; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; FLATULENCE; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE;

ADULT; CONSTIPATION; CROSS-SECTIONAL STUDIES; FEMALE; FLATULENCE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 84958819104     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12758     Document Type: Article

References (32)

1. Jiang X, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Knill-Jones Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut 2008; 57: 756-63.
2. Iovino P, Bucci C, Tremolaterra F, Santonicola A, Chiarioni G. Bloating and functional gastro-intestinal disorders: where are we and where are we going? World J Gastroenterol 2014; 20: 14407-19.
3. Schmulson M, Chang L. Review article: the treatment of functional abdominal bloating and distension. Aliment Pharmacol Ther 2011; 33: 1071-86. doi:10.1111/j.1365-2036.2011.04637.x.
4. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4.
5. Lembo T, Naliboff B, Munakata J, Fullerton S, Saba L, Tung S, Schmulson M, Mayer EA. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999; 94: 1320-6.
6. Sach J, Bolus R, Fitzgerald L, Naliboff B, Chang L, Mayer E. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients? Am J Gastroenterol 2002; 12: 3131-8.
7. Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA, Peacock RA, Wilson IK et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol 2003; 38: 947-54.
8. Thompson WG, Longstreth G, Drossman DA, Heaton K, Irvine EJ, Muller-Lissner SC. Functional bowel disorders in functional abdominal pain. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. The Functional Gastrointestinal Disorders, 2nd edn. McLean, VA: Degnon Associates, 2000: 351-432.
9. Hernando-Harder AC, Serra J, Azpiroz F, Milà M, Aguadé S, Malagelada C, Tremolaterra F, Villoria A et al. Colonic responses to gas loads in subgroups of patients with abdominal bloating. Am J Gastroenterol 2010; 105: 876-82.
10. Koloski NA, Boyce PM, Jones MP, Talley NJ. What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful? Qual Life Res 2012; 21: 829-36. doi:10.1007/s11136-011-9985-5.
11. Ringel Y, Williams RE, Kalilani L, Cook SF. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2009; 7: 68-72. doi:10.1016/j.cgh.2008.07.008; quiz 3.
12. Neri L, Basilisco G, Corazziari E, Stanghellini V, Bassotti G, Bellini M, Perelli I, Cuomo R et al. Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation. United European Gastroenterol J 2014; 2: 138-47.
13. Apolone G, Mosconi P, Quattrocchi L. Questionario sullo stato di salute SF-12. Versione italiana. Ed. Guerini e Associati, published on January 2005. ISBN: 8883352017
14. Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 1999; 34: 870-7.
15. Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 2005; 8 (Suppl. 1): S9-24.
16. Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther 2009; 17: 163-70.
17. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
18. Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 2007; 7: 541-6.
19. Emmanuel A, Quigley EM, Simrén M, Feng Y, Müller-Lissner S, Urbain D, Tack J, Bredenoord AJ et al. Factors affecting satisfaction with treatment in European women with chronic constipation: an internet survey. United European Gastroenterol J 2013; 1: 375-84.
20. Azpiroz F, Serra J. Treatment of excessive intestinal gas. Curr Treat Opin Gastroenterol 2004; 7: 299-305.
21. Müller-Lissner SA, Fumagalli I, Bardhan KD, Pace F, Pecher E, Nault B, Rüegg P et al. Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001; 15: 1655-66.
22. Grider JR, Kuemmerle JF, Jin JG. 5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1P receptors on sensory CGRP neurons. Am J Physiol 1996; 270: G778-82.
23. Coleski R, Owyang C, Hasler WL. Modulation of intestinal gas dynamics in healthy human volunteers by the 5-HT receptor agonist tegaserod. Am J Gastroenterol 2006; 101: 1858-65.
24. Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation predominant irritable bowel syndrome. Gastroenterology 2000; 118: 463-8.
25. Anderson JL, May HT, Blair TL, Muhlestein JB, Horne BD, Carlquist JF. Association of tegaserod with cardiovascular outcomes in a matched study of 18, 221 treated and untreated patients. Eur Heart J 2008; 29 (Suppl.): 755.
26. Tack J, Stanghellini V, Dubois D, Joseph A, Vandeplassche L, Kerstens R. Effect of prucalopride on symptoms of chronic constipation. Neurogastroenterol Motil 2014; 26: 21-7. doi:10.1111/nmo.12217.
27. De Schryver AM, Andriesse GI, Samsom M, Smout AJ, Gooszen HG, Akkermans LM. The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers. Aliment Pharmacol Ther 2002; 16: 603-12.
28. Wong BS, Manabe N, Camilleri M. Role of prucalopride, a serotonin (5-HT4) receptor agonist, for the treatment of chronic constipation. Clin Exp Gastroenterol 2010; 3: 49-56.
29. Lacy BE, Schey R, Shiff SJ, Lavins BJ, Fox SM, Jia XD, Blakesley RE, Hao X et al. Linaclotide in chronic idiopathic constipation patients with moderate to severe abdominal bloating: a randomized, controlled trial. PLoS ONE 2015; 10: e0134349.
30. Spiegel BM, Kanwal F, Naliboff B, Mayer E. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am J Gastroenterol 2005; 100: 2262-73.
31. Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther 2015; 41: 1256-70.
32. Hebden JM, Blackshaw E, D'Amato M, Perkins AC, Spiller RC. Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms. Am J Gastroenterol 2002; 97: 2315-20.